Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Leids onderzoek bevestigt effectiviteit nieuw malariamiddel
feb 2024 | Parasitaire infecties